Biospecimens procurement processes overview by BIOMEDICA CRO
Biospecimen procurement can be rather challenging for sourcing managers. Usually, they are between biospecimen vendors and in-house scientists. But in reality, the supply chain may be even longer and not transparent enough when vendors outsource sample collection by one more or even more bio-brokers.
It is nearly impossible to fulfill original scientist requests when your messages have to pass through several intermediates and finally reach the primary investigator (a physician who collects biospecimens) in a completely changed form. In such cases communication process goes like this:
- The researchers tell the sourcing manager what kind of biosamples they need;
- The procurement manager places a request on the marketplace or contacts the biospecimen vendor;
- Vendor may not have their own collection capacities, so they have to contact other specialized biospecimen company which is going to be responsible for human samples collection;
- A specialized biospecimen company finally approaches the primary investigators, and they start sample collection.
The path from the initial scientist’s need to the final execution is rather complicated. Many necessary details may be missed in this way, causing mistakes in the sample collection process. In addition, communication goes back and forth while the project is stuck, crushing the deadlines and ruing scientific plans.
It may become even worse when you need to change or modify some requirements during the project, which again requires additional communication with numerous vendors.
Now imagine that you are in a hurry and project timelines are the priority. What results will you have then? In such challenging circumstances, this question sounds somewhat rhetorical. Even when you have enough time (which is rather exceptional), the likelihood that all project details and conditions will be strictly followed is critically low.
The best way to solve this issue is to shorten the distance between the project owner and the final executor. The best option for that might be BIOMEDICA CRO, as the company that has only its own human biospecimen collection but no brokerage of other companies’ samples.
“Human biospecimen procurement is easy with BIOMEDICA CRO,” states Iryna Iurkova, Business Development Director of BIOMEDICA CRO
By collecting specimens by ourselves, we ensure easy, fast, and faultless communication with the executors. BIOMEDICA CRO team is in constant contact with clinical sites as well as primary investigators (physicians) and is always ready to provide you with the latest collection feedback. Direct contact with physicians ensures their proper understanding of collection details and the high quality of collected biospecimens.
Please email us to start our collaboration at office@biomedica-cro.com / LinkedIn or visit our page to find out more about BIOMEDICA CRO.
